ZJ1 Stock Overview

Operates as an online pharmacy and beauty store company in Italy. More details

ZJ1 fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	1/6
Past Performance	0/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 52.1% below our estimate of its fair value

Revenue is forecast to grow 8.5% per year

Risk Analysis

Volatile share price over the past 3 months compared to the German market

Does not have a meaningful market cap (€36M)

Currently unprofitable and not forecast to become profitable over the next 3 years

My Notes

Capture your thoughts, links and company narrative

Farmacosmo S.p.A. Competitors

Artnet

XTRA:ART

€39.4m

Mister Spex

XTRA:MRX

€53.3m

Bike24 Holding

XTRA:BIKE

€48.4m

Weng Fine Art

DB:WFA

€21.3m

Price History & Performance

Summary of share price highs, lows and changes for Farmacosmo
Historical stock prices
Current Share Price	€0.50
52 Week High	€1.10
52 Week Low	€0.35
Beta	0.81
1 Month Change	8.62%
3 Month Change	-13.99%
1 Year Change	-21.74%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-77.45%

Recent updates

Shareholder Returns

	ZJ1	DE Specialty Retail	DE Market
7D	0%	-0.02%	0.3%
1Y	-21.7%	29.9%	6.9%

Return vs Industry: ZJ1 underperformed the German Specialty Retail industry which returned 29.9% over the past year.

Return vs Market: ZJ1 underperformed the German Market which returned 6.9% over the past year.

Price Volatility

Is ZJ1's price volatile compared to industry and market?
ZJ1 volatility
ZJ1 Average Weekly Movement	10.6%
Specialty Retail Industry Average Movement	5.7%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.8%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: ZJ1's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: ZJ1's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

Founded	Employees	CEO	Website
n/a	85	Fabio de Concilio	www.farmacosmo.it

Farmacosmo S.p.A. operates as an online pharmacy and beauty store company in Italy. It offers health and pharmacy, bath and body, skincare, haircare, sun and tanning, dental care, fragrance, make up, baby and child, and organic and natural products, as well as vitamins and supplements, toys, food cupboards, pets, and household products. The company is headquartered in Naples, Italy.

Farmacosmo S.p.A. Fundamentals Summary

How do Farmacosmo's earnings and revenue compare to its market cap?
ZJ1 fundamental statistics
Market cap	€36.48m
Earnings (TTM)	-€3.94m
Revenue (TTM)	€68.16m

0.5x

P/S Ratio

-9.3x

P/E Ratio

Is ZJ1 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ZJ1 income statement (TTM)
Revenue	€68.16m
Cost of Revenue	€67.43m
Gross Profit	€726.84k
Other Expenses	€4.67m
Earnings	-€3.94m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.10
Gross Margin	1.07%
Net Profit Margin	-5.79%
Debt/Equity Ratio	52.0%

How did ZJ1 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/31 23:23
End of Day Share Price	2024/12/23 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Farmacosmo S.p.A. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Luisa Primi	IR Top Consulting S.r.l.
Federico Zangaro	IR Top Consulting S.r.l.
Marco Greco	ValueTrack